Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects
Nagai, Noriaki, Ogata, Fumihiko, Otake, Hiroko, Kawasaki, NaohitoVolume:
12
Journal:
Pharmaceutics
DOI:
10.3390/pharmaceutics12040313
Date:
April, 2020
File:
PDF, 3.72 MB
2020